MALKY FETMAN: Open Payments
NPI 1639878903 · DEPTFORD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$110 in 7 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $119 · 2025 $110
Food & beverage: $110
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| KYOWA KIRIN, INC. | 1 | $18 |
| BioMarin Pharmaceutical Inc. | 1 | $17 |
| Seqirus USA Inc | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $14 |
| GENZYME CORPORATION | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
Products named: VPRIV, CRYSVITA, VOXZOGO 1.2mg, Flucelvax, ROTATEQ, CEREZYME, ZORYVE.
Industry payments across NJ — which companies pay providers there.
